Coronavirus disease 2019 and type 1 diabetes mellitus.
Curr Opin Endocrinol Diabetes Obes
; 28(1): 35-42, 2021 02 01.
Article
in English
| MEDLINE | ID: covidwho-1052225
ABSTRACT
PURPOSE OF REVIEW Type 2 diabetes (T2DM) is a major comorbidity of coronavirus disease 2019 (COVID-19) but less is known about COVID-19 and type 1 diabetes (T1DM). Thus, our goal was to review the literature on COVID and T1DM. RECENT FINDINGS:
We identified 21 reports focusing on COVID-19 infections among patients with preexisting T1DM (nâ=â7), incident T1DM presentations during the COVID-19 quarantine (nâ=â6), and outpatient management of T1DM during the COVID-19 quarantine (nâ=â8). These studies showed that patients with preexisting T1DM and COVID-19 infection often present with hyperglycemia and/or diabetic ketoacidosis (DKA). Although the risk of in-hospital mortality may be increased, hospitalization rates among patients with T1DM mirror that of the general population. The numbers of patients presenting with incident T1DM during COVID-19 quarantine have remained stable, but cases with severe DKA may have increased. COVID-19 quarantine has also impacted outpatient T1DM management and studies examining changes in glycemic control have shown mixed results.SUMMARY:
COVID-19 has important implications for patients with type 1 diabetes, but additional studies with larger numbers of patients and longer term follow-up are needed to confirm the early findings highlighted in this review.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 1
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Curr Opin Endocrinol Diabetes Obes
Journal subject:
Endocrinology
/
Metabolism
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS